• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

实验性脑内血肿的纤溶和抽吸可减少大鼠缺血性脑体积。

Fibrinolysis and aspiration of experimental intracerebral hematoma reduces the volume of ischemic brain in rats.

作者信息

Deinsberger W, Vogel J, Fuchs C, Auer L M, Kuschinsky W, Böker D K

机构信息

Neurosurgical Clinic, Justus-Liebig University Giessen, Germany.

出版信息

Neurol Res. 1999 Jul;21(5):517-23.

PMID:10439435
Abstract

The hypothesis was tested in rats that brain ischemia by an intracerebral hematoma can be ameliorated by fibrinolysis and aspiration of the hematoma. Intraparenchymal blood clots were generated by the injection of 50 microliters of autologous blood into the right caudate nucleus in two portions seven minutes apart. Thirty or 120 min later 12 microliters recombinant tissue plasminogen activator (rtPA) or 0.9% NaCl were injected and after 30 min the resolved hematoma was aspirated. Six hours later cerebral blood flow (CBF) was determined by 14C-iodoantipyrine autoradiography. Tissue volumes of CBF < 10 ml 100 g-1 min-1 and CBF < 30 ml g-1 min-1 were determined. Clot and lesion volume were quantified histologically from serial sections stained for succinate-dehydrogenase (SDH) activity. In rtPA-treated rats the major part of the hematoma could be evacuated 30 min as well as 120 min after production of the clot. The volume of ischemic brain (CBF < 10) was significantly reduced (p < 0.05) in the rtPA group compared to saline-treated and control groups irrespective of the time of treatment. In contrast, no difference was found between the control group and the experimental groups when the volumes of brain tissue surrounding the lesion were compared which had values of CBF < 30 ml 100 g-1 min-1. In a rat model of intracerebral hemorrhage, treatment by local fibrinolysis followed by aspiration of the hematoma is effective in reducing the volume of ischemic brain tissue and of the remaining clot volume.

摘要

在大鼠中对以下假说进行了验证

脑内血肿所致的脑缺血可通过纤溶和血肿抽吸得到改善。通过将50微升自体血分两部分、间隔7分钟注入右侧尾状核来形成脑实质内血凝块。30或120分钟后,注入12微升重组组织型纤溶酶原激活剂(rtPA)或0.9%氯化钠溶液,30分钟后将溶解的血肿吸出。6小时后,通过14C-碘安替比林放射自显影术测定脑血流量(CBF)。测定CBF<10 ml 100 g-1 min-1和CBF<30 ml g-1 min-1时的组织体积。通过对琥珀酸脱氢酶(SDH)活性染色的连续切片进行组织学定量分析血凝块和病变体积。在rtPA治疗的大鼠中,血凝块形成后30分钟和120分钟时,大部分血肿均可被吸出。与盐水治疗组和对照组相比,rtPA组缺血性脑体积(CBF<l0)显著减小(p<0.05),且与治疗时间无关。相比之下,当比较病变周围CBF<30 ml 100 g-1 min-1的脑组织体积时,对照组与实验组之间未发现差异。在脑出血大鼠模型中,局部纤溶后抽吸血肿的治疗方法可有效减少缺血性脑组织体积和剩余血凝块体积。

相似文献

1
Fibrinolysis and aspiration of experimental intracerebral hematoma reduces the volume of ischemic brain in rats.实验性脑内血肿的纤溶和抽吸可减少大鼠缺血性脑体积。
Neurol Res. 1999 Jul;21(5):517-23.
2
Fibrinolysis therapy achieved with tissue plasminogen activator and aspiration of the liquefied clot after experimental intracerebral hemorrhage: rapid reduction in hematoma volume but intensification of delayed edema formation.在实验性脑出血后,使用组织纤溶酶原激活剂实现纤溶治疗并抽吸液化血凝块:血肿体积迅速减小,但延迟性水肿形成加剧。
J Neurosurg. 2002 Oct;97(4):954-62. doi: 10.3171/jns.2002.97.4.0954.
3
Comparison of frame-based and frameless stereotactic hematoma puncture and subsequent fibrinolytic therapy for the treatment of supratentorial deep seated spontaneous intracerebral hemorrhage.基于框架和无框架立体定向血肿穿刺及后续纤溶治疗用于幕上深部自发性脑出血治疗的比较
Minim Invasive Neurosurg. 2007 Apr;50(2):86-90. doi: 10.1055/s-2007-982503.
4
Reperfusion after thrombolytic therapy of embolic stroke in the rat: magnetic resonance and biochemical imaging.大鼠栓塞性中风溶栓治疗后的再灌注:磁共振与生化成像
J Cereb Blood Flow Metab. 1998 Apr;18(4):407-18. doi: 10.1097/00004647-199804000-00009.
5
Effect of combined therapy with thrombolysis and citicoline in a rat model of embolic stroke.溶栓与胞磷胆碱联合治疗对大鼠栓塞性脑卒中模型的影响。
J Neurol Sci. 2006 Sep 25;247(2):121-9. doi: 10.1016/j.jns.2006.03.022. Epub 2006 Jun 22.
6
[Leukotriene synthesis after intracerebral hemorrhage: a further indicator for their pathophysiologic significance in the CNS].
Zentralbl Neurochir. 1998;59(2):113-20.
7
The role of endogenous versus exogenous tPA on edema formation in murine ICH.内源性与外源性组织型纤溶酶原激活剂在小鼠脑出血水肿形成中的作用。
Exp Neurol. 2004 Sep;189(1):25-32. doi: 10.1016/j.expneurol.2004.05.021.
8
Ultra-early clot aspiration after lysis with tissue plasminogen activator in a porcine model of intracerebral hemorrhage: edema reduction and blood-brain barrier protection.在猪脑出血模型中,使用组织型纤溶酶原激活剂溶解血栓后进行超早期血栓抽吸:减轻水肿和保护血脑屏障
J Neurosurg. 1999 Mar;90(3):491-8. doi: 10.3171/jns.1999.90.3.0491.
9
Hematoma expansion in experimental intracerebral hemorrhage is not altered by peracute treatment with recombinant tissue plasminogen activator.实验性脑出血中血肿扩大不会因重组组织型纤溶酶原激活剂的超急性期治疗而改变。
Neuroscience. 2013 Oct 10;250:181-8. doi: 10.1016/j.neuroscience.2013.07.003. Epub 2013 Jul 13.
10
Local fibrinolysis and aspiration of intracerebral hematomas in rats. An experimental study using MR monitoring.
Neurol Res. 1998 Jun;20(4):349-52. doi: 10.1080/01616412.1998.11740530.

引用本文的文献

1
Optimized tPA: A non-neurotoxic fibrinolytic agent for the drainage of intracerebral hemorrhages.优化 tPA:一种非神经毒性的纤维蛋白溶解剂,用于引流脑出血。
J Cereb Blood Flow Metab. 2018 Jul;38(7):1180-1189. doi: 10.1177/0271678X17719180. Epub 2017 Jul 25.
2
Poxue Huayu and Tianjing Busui Decoction for cerebral hemorrhage (Upregulation of neurotrophic factor expression): Upregulation of neurotrophic factor expression.补阳还五汤合天经补髓汤治疗脑出血(上调神经营养因子表达):上调神经营养因子表达。
Neural Regen Res. 2013 Aug 5;8(22):2039-49. doi: 10.3969/j.issn.1673-5374.2013.22.003.
3
MRI of the perihemorrhagic zone in a rat ICH model: effect of hematoma evacuation.
大鼠脑出血模型中出血周围区域的磁共振成像:血肿清除的影响
Neurocrit Care. 2008;8(3):448-55. doi: 10.1007/s12028-007-9047-6.
4
Intracranial hemorrhage: the role of magnetic resonance imaging.颅内出血:磁共振成像的作用
Neurocrit Care. 2004;1(1):31-45. doi: 10.1385/NCC:1:1:31.
5
Intracerebral hemorrhage: pathophysiology and therapy.脑出血:病理生理学与治疗
Neurocrit Care. 2004;1(1):5-18. doi: 10.1385/ncc:1:1:5.